Oncologists Accepting Curative in Boston, MA
126 verified oncologists in Boston, Massachusetts accept Curative. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Newton-wellesley Hospital.
Ursula Matulonis, MD
Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute
Oncology
Robert Haddad, MD
Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School
Oncology
Patrick Ott, MD
Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician
Oncology
Kenneth Anderson, MD
Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
Oncology
Mary-Ellen Taplin, MD
Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Oncology
Muneeb Ahmed, M.D.
Miriam H. Stoneman Professor of Radiology, Harvard Medical School; Chief, Division of Vascular and Interventional Radiology, Beth Israel Deaconess Medical Center; Chair of the Imaging Department, Dana-Farber Cancer Institute
Oncology
Vincent Ho, MD
Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute
Oncology
Susana Campos, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Oncology
Suzanne George, MD
Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School
Oncology
Himisha Beltran, MD
Associate Professor of Medicine, Lank Center for Genitourinary Oncology and Division of Molecular and Cellular Oncology; Director of Translational Research, Medical Oncology
Oncology
Joseph Antin, MD
Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus
Oncology
Jennifer Chan, MD
Associate Professor of Medicine, Harvard Medical School; Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute
Oncology
Robert Soiffer, MD
Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Oncology
Harold Burstein, MD PHD
Director of Academic Partnerships; Director of Breast Cancer Education
Oncology
Liangge Hsu, MD
Assistant Professor of Radiology
Oncology
Howard Kaufman, M.D.
Professor, Surgery
Oncology
Arnold Freedman, MD
Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School
Oncology
Erica Mayer, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program
Oncology
William Mayo-Smith, MD
Professor of Radiology
Oncology
Ann Partridge, MD MPH
Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you
Oncology